ArticleMedicine2022

New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: A case report.

Je Hyun Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.